| Series |
Opposing viewpoints series |
|
Opposing viewpoints series (Unnumbered)
|
| Bibliography |
Includes bibliographical references (p. 195-199) and index. |
| Contents |
Why consider opposing viewpoints? -- Introduction -- ch. 1. Is pharmaceutical research safe and unbiased? -- Chapter preface -- 1. Pharmaceutical clinical trials save lives / Jan Jarboe Russell -- 2. Pharmaceutical clinical trials imperil lives / David Evans, Michael Smith, and Liz Willen -- 3. Drug industry-funded research is biased / Leonard Glantz, as told to Sara Hoffman Jurand -- 4. Most drug industry-funded research is not biased / Ronald Bailey -- 5. Requiring clinical trials registration would ensure patients' safety / Iain Chalmers, as told to the Bulletin of the World Health Organization -- 6. Requiring clinical trials registration would hinder drug development / International Federation of Pharmaceutical Manufacturers & Associations -- Periodical bibliography -- ch. 2. Are prescription drugs appropriately regulated? -- Chapter preface -- 1. The FDA actively regulates drug safety / Henry I. Miller -- 2. Terminal patients should be allowed to take unapproved medications / Scott Ballenger, as told to Margot Adler -- 3. Terminal patients should not be allowed access to unapproved medications / Ralph W. Moss -- 4. The FDA should not allow pharmacists to dispense behind-the-counter drugs / Rick Kellerman -- 5. The FDA's black box warnings on antidepressants did not cause an increase in youth suicides / Alison Bass -- Periodical bibliography -- |
|
ch. 3. Are pharmaceutical marketing practices ethical? -- Chapter preface -- 1. Drug detailing greatly influences doctors' prescribing habits / Carl Elliott -- 2. Drug detailing has little influence on doctors' prescribing habits / Natalie Mizik and Robert Jacobson -- 3. Direct-to-consumer drug marketing educates patients / Sal Perreca -- 4. Direct-to-consumer drug marketing harms patients / Peter R. Mansfield -- 5. Drug manufacturers' efforts to educate doctors are legitimate and ethical / The Pharmaceutical Research and Manufacturers of America -- 6. Drug manufacturers' efforts to educate doctors are unethical / Marcia Angell -- Periodical bibliography -- ch 4. Is the cost of prescription drugs in America appropriate? -- Chapter preface -- 1. The cost of prescription drugs is justified / Richard A. Epstein -- 2. The cost of prescription drugs is outrageous / Alliance for Retired Americans Educational Fund -- 3. Americans should be able to buy cheaper drugs outside the country / Gil Gutknecht -- 4. Americans should not be permitted to buy drugs outside the country / Michelle Plasari -- 5. The government should allow price negotiations for Medicare drugs / National Committee to Preserve Social Security and Medicare -- 6. The government should not allow price negotiations for Medicare drugs / Benjamin Zycher -- Periodical bibliography -- For further discussion -- Organizations to contact -- Bibliography of books -- Index. |
| Access |
Access limited to licensed institutions. |
| Subject |
Drug development -- Popular works.
|
|
Drugs -- Research -- Popular works.
|
|
Pharmaceutical industry -- Popular works.
|
| Genre/Form |
Electronic books.
|
| Added Author |
Carroll, Jamuna.
|
| ISBN |
9780737742381 (hardcover) |
|
0737742380 (hardcover) |
|
9780737742398 (pbk.) |
|
0737742399 (pbk.) |
|
